Healthy Hearts: Leveraging the Diabetes Prevention Program to Decrease Health Disparities in Women of Reproductive Age
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prediabetic State
- Sponsor
- The University of Texas Medical Branch, Galveston
- Primary Endpoint
- Change from Baseline Triglycerides at 12 months
- Status
- Withdrawn
- Last Updated
- 3 years ago
Overview
Brief Summary
Nearly half of women have obesity and/or hypertension (HTN). Specific to women, pregnancy creates a vulnerable window for excess gestational weight gain (GWG), exacerbating intergenerational risks for obesity, HTN, type 2 diabetes (T2D), and cardiovascular disease (CVD) across the lifespan. Healthy lifestyles are the first-line recommendations for prevention and treatment of overweight/obesity, HTN, T2D, and CVD. The Diabetes Prevention Program (DPP) is a well-established, Centers for Disease Control and Prevention (CDC)-led public health program focusing on healthy lifestyle changes and is effective at reducing 5-7% of body weight, lowering risks for T2D. Interestingly, research investigating the DPP as a lifestyle intervention for other chronic conditions (i.e., overweight/obesity and HTN) is lacking, demonstrating a missed opportunity. The aim of this study is to determine the initial effects of the first 6-months and after receiving the full 12-months of the virtual DPP compared to the DPP expanded with a CDC-approved HTN prevention component (DPP+) on physical activity, diet, weight, and CVD risk factors in 30 prediabetic women (18-45 years old) with a history of excess GWG, overweight/obesity, and HTN. Participants will be recruited through University of Texas Medical Branch (UTMB) community-based clinics using Epic. The Participants will be randomized into 2 groups (DPP and DPP+) and guided through the 12-month virtual DPP or DPP+ program using UTMB DPP personnel.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women with prediabetes and eligible for the DPP, overweight/obesity, HTN (diagnosed or 3 successive high blood pressure readings), and history of excess gestational weight gain during most recent pregnancy
Exclusion Criteria
- •Pregnant and lactating women, participants planning to move out of Galveston County within the next year
Outcomes
Primary Outcomes
Change from Baseline Triglycerides at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Low-density lipoproteins at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Systolic Blood Pressure at 6 months
Time Frame: Baseline, 6-months
Change from Baseline High-density lipoproteins at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Low-density lipoproteins at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Diastolic Blood Pressure at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Diastolic Blood Pressure at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Systolic Blood Pressure at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Total cholesterol at 6 months
Time Frame: Baseline, 6-months
Change from Baseline High-density lipoproteins at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Fasting blood glucose at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Triglycerides at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Total cholesterol at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Hemoglobin a1c at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Weight at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Fasting blood glucose at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Hemoglobin a1c at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Weight at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Body mass index at 12 months
Time Frame: Baseline, 12-months
Change from Baseline Body mass index at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Serum insulin at 6 months
Time Frame: Baseline, 6-months
Change from Baseline Serum insulin at 12 months
Time Frame: Baseline, 12-months
Secondary Outcomes
- Change from Baseline Total portions of Combined Weekly Fruit and Vegetable Consumption at 12 months(Baseline, 12-months)
- Change from Baseline Total portions of Fried Food Consumption at 6 months(Baseline, 6-months)
- Change from Baseline Subjective Weekly Physical activity at 6 months(Baseline, 6-months)
- Change from Baseline Total portions of Combined Weekly Fruit and Vegetable Consumption at 6 months(Baseline, 6-months)
- Change from Baseline Objective Total Weekly Physical activity minutes at 6 months(Baseline, 6-months)
- Change from Baseline Visceral adiposity tissue at 6 months(Baseline, 6-months)
- Change from Baseline C-reactive protein at 12 months(Baseline, 12-months)
- Change from Baseline Total portions of Fried Food Consumption at 12 months(Baseline, 12-months)
- Change from Baseline Subjective Weekly Physical activity at 12 months(Baseline, 12-months)
- Change from Baseline Objective Total Weekly Physical activity minutes at 12 months(Baseline, 12-months)
- Change from Baseline C-reactive protein at 6 months(Baseline, 6-months)
- Change from Baseline Visceral adiposity tissue at 12 months(Baseline, 12-months)